https://cn.quancapital.com/en/portfolio-category/all-exited/ 2026-03-19T07:52:33+00:00 https://cn.quancapital.com/en/portfolio-category/all-not-exited/ 2026-03-19T09:48:53+00:00 https://cn.quancapital.com/en/portfolio-category/biotech-company-specializing-in-non-absorbable-drugs-for-metabolic-diseases/ 2026-01-13T07:55:03+00:00 https://cn.quancapital.com/en/portfolio-category/biotechnology-company-focused-on-accelerating-breakthroughs-in-protein-conjugate-therapeutic-development-for-cancer-and-other-life-threatening-diseases/ 2024-02-29T07:46:59+00:00 https://cn.quancapital.com/en/portfolio-category/biotechnology-company-focused-on-developing-first-in-class-oral-peptide-pipeline-against-validated-biologic-targets-with-large-unmet-needs/ 2026-03-19T09:48:53+00:00 https://cn.quancapital.com/en/portfolio-category/developing-a-new-class-of-therapies-for-degenerative-disorders-caused-by-nucleotide-repeat-expansions/ 2021-06-03T07:31:18+00:00 https://cn.quancapital.com/en/portfolio-category/clinical-stage-biotech-developing-immune-based-therapies-for-the-world/ 2024-11-28T06:32:06+00:00 https://cn.quancapital.com/en/portfolio-category/clinical-stage-biotech-discovering-and-developing-allogeneic-gamma-delta-t-cell-therapies/ 2020-11-19T10:32:28+00:00 https://cn.quancapital.com/en/portfolio-category/discovering-and-developing-first-in-class-immunotherapy-based-biologics-for-cancer-and-other-diseases/ 2020-08-20T09:52:43+00:00 https://cn.quancapital.com/en/portfolio-category/breakthrough-therapies-in-the-complement-space/ 2024-07-03T03:28:25+00:00 https://cn.quancapital.com/en/portfolio-category/biotechnology-company-focused-on-developing-breakthrough-car-t-cell-therapies/ 2022-03-07T10:41:23+00:00 https://cn.quancapital.com/en/portfolio-category/small-molecule-oncology-company-focusing-on-immune-related-pathways/ 2025-12-01T09:35:44+00:00 https://cn.quancapital.com/en/portfolio-category/clinical-stage-biotechnology-company-focused-on-developing-the-next-generation-of-oncology-therapies-for-patients/ 2024-04-01T05:52:52+00:00 https://cn.quancapital.com/en/portfolio-category/leading-biotech-focusing-on-innovative-ophthalmology-drugs-in-china/ 2021-11-10T07:12:35+00:00 https://cn.quancapital.com/en/portfolio-category/drug-development-company-committed-to-improving-outcomes-for-people-living-with-advanced-immunological-diseases-with-an-initial-focus-on-severe-respiratory-conditions/ 2025-07-02T08:18:56+00:00 https://cn.quancapital.com/en/portfolio-category/leveraging-unique-algorithms-to-facilitate-data-driven-life-science-research/ 2021-08-12T09:48:12+00:00 https://cn.quancapital.com/en/portfolio-category/first-in-class-clinical-pipeline-targeting-gene-control-in-oncology/ 2020-08-20T09:53:43+00:00 https://cn.quancapital.com/en/portfolio-category/future-leader-with-state-of-the-art-circular-rna-platform-to-leverage-the-transformational-features-and-enable-a-vast-number-of-potential-applications/ 2024-03-07T02:59:32+00:00 https://cn.quancapital.com/en/portfolio-category/innovative-minimal-invasive-medtech-for-early-stage-lung-cancer-treatment/ 2020-06-04T09:26:41+00:00 https://cn.quancapital.com/en/portfolio-category/late-stage-immuno-oncology-biotech-with-novel%ef%bc%8cproprietary-pipeline/ 2020-07-22T09:02:33+00:00 https://cn.quancapital.com/en/portfolio-category/biopharmaceutical-company-developing-therapies-for-the-treatment-of-renal-diseases-and-related-chronic-conditions/ 2022-04-15T18:43:08+00:00 https://cn.quancapital.com/en/portfolio-category/an-integrated-platform-for-rare-disease-drug-development-and-commercialization-in-china/ 2021-08-10T06:45:28+00:00 https://cn.quancapital.com/en/portfolio-category/late-stage-immuno-oncology-biotech-with-novel%ef%bc%8cproprietary-pipeline-2/ 2020-08-20T09:51:49+00:00 https://cn.quancapital.com/en/portfolio-category/leading-china-biotech-of-cell-therapy-with-breakthrough-in-solid-tumor/ 2023-12-05T05:15:22+00:00 https://cn.quancapital.com/en/portfolio-category/developing-new-modality-drugs-to-address-unmet-clinical-needs/ 2022-07-01T04:26:06+00:00 https://cn.quancapital.com/en/portfolio-category/leading-chinese-specialty-clinical-development-cro-that-serves-local-and-global-biotech-pharma-clients/ 2020-07-22T09:29:43+00:00 https://cn.quancapital.com/en/portfolio-category/leading-digital-platform-for-lifestyle-management-in-china-and-us/ 2020-08-10T03:01:35+00:00 https://cn.quancapital.com/en/portfolio-category/precision-medicine-leader-in-china-offering-integrated-solutions-of-biomarkers%ef%bc%8ccompanion-diagnostics-and-clinical-testing/ 2020-08-10T03:09:20+00:00 https://cn.quancapital.com/en/portfolio-category/preclinical-stage-gene-therapy-company-developing-a-paradigm-shifting-platform-for-in-vivo-cell-specific-gene-delivery/ 2026-03-19T07:52:33+00:00 https://cn.quancapital.com/en/portfolio-category/uk-biotech-developing-potent%ef%bc%8cmulti-functional-humabody-therapeutics/ 2018-11-15T08:21:58+00:00